Event Details
Monday, August 29, 6:30 pm to 8:30 pm
Cross Campus, 85 N. Raymond Avenue, Pasadena, CA
Biomedical companies have shifted financing sources from early VC to strategic partnerships, and subsequently exits in the form of acquisitions over IPOs. As such, FDA clearance has been overtaken by reimbursement and an effective payer strategy, in which a dossier of supporting peer-reviewed publications is paramount to reimbursement and acquisition. This evening's presentation focuses on the importance of developing and executing an effective publication strategy. RSVP NOW
- Monday — August 29, 2016
6:30PM - 8:30PM - Cross Campus Pasadena
87 N Raymond Ave
Pasadena, CA 91103
View Map